ARTICLE | Distillery Therapeutics
Cancer
April 10, 2018 10:54 PM UTC
Patient sample, cell culture, and mouse studies suggest inhibiting IKKα could help treat KRAS-mutant lung adenocarcinoma. In patient samples, levels of IKKα were higher in tumors than in adjacent norm...
BCIQ Company Profiles